Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fayers
Madeleine King

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Palliative Medicine|May 13, 2017
Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care TrialMogens Groenvold, Morten Aagaard Petersen, Anette Damkier, et al.
Trials|September 27, 2014
Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT)Anna Thit Johnsen, Morten Aagaard Petersen, Christian Gluud, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 20, 2018
Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Rebecca Mercieca-Bebber, Douglas Williams, Margaret-Ann Tait, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 18, 2018
Correction to: Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Rebecca Mercieca-Bebber, Douglas Williams, Margaret-Ann Tait, et al.
The Oncologist|March 25, 2015
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variablesMing Sze, Phyllis Butow, Melanie Bell, et al.
Plos Medicine|May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewJenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Palliative Medicine|May 13, 2017
Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care TrialMogens Groenvold, Morten Aagaard Petersen, Anette Damkier, et al.
Trials|September 27, 2014
Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT)Anna Thit Johnsen, Morten Aagaard Petersen, Christian Gluud, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 20, 2018
Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Rebecca Mercieca-Bebber, Douglas Williams, Margaret-Ann Tait, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 18, 2018
Correction to: Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Rebecca Mercieca-Bebber, Douglas Williams, Margaret-Ann Tait, et al.
The Oncologist|March 25, 2015
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variablesMing Sze, Phyllis Butow, Melanie Bell, et al.
Plos Medicine|May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewJenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
The Lancet. Oncology|August 2, 2017
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialGillian M Duchesne, Henry H Woo, Madeleine King, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.
Pageof 18